by Jessica Casebolt | Jun 11, 2024 | Life Sciences, Tea Leaves
A closely watched Alzheimer’s drug from Eli Lilly won the backing of federal health advisers on Monday, setting the stage for the treatment’s expected approval for people with mild dementia caused by the brain-robbing disease. Food and Drug Administration (FDA)...
by Jessica Casebolt | May 30, 2024 | Life Sciences, Tea Leaves
A study published in JAMA Network Open, drawing from data collected through the Apple Research App involving over 71,000 women, reveals a concerning trend: the age at which girls in the United States experience their first period is declining, while the time it takes...
by Jessica Casebolt | May 29, 2024 | Life Sciences, Tea Leaves
A recent study analyzing 25 years of birth data suggests that heat waves are associated with slight increases in premature and early-term births, with risks escalating as extreme temperatures persist, posing a potential threat to infant health amidst climate change....
by Jessica Casebolt | May 22, 2024 | Life Sciences, Tea Leaves
A new study found that a remote patient monitoring program reduced costs and improved outcomes for heart failure patients. The program demonstrated a significant 52 percent cost reduction per month for Medicare beneficiaries. The study involved over 350 patients and...
by Jessica Casebolt | May 20, 2024 | Life Sciences, Tea Leaves
Starting Monday, a new federal transparency rule will revolutionize drug advertising by mandating clear disclosure of potential side effects and when to avoid medication. This update of a 2007 law empowers the Food and Drug Administration (FDA) in advertising...
by Jessica Casebolt | May 17, 2024 | Life Sciences, Tea Leaves
The U.S. Justice Department on Thursday unveiled a historic proposal to ease restrictions on marijuana, a rule that, if enacted, would also enable more research on its medicinal benefits. The proposal, first announced in April, would reclassify cannabis from a...
Recent Comments